ChronoScale Corporation Common Stock (NASDAQ:CHRN) Trading Up 6.6% – Here’s Why

ChronoScale Corporation Common Stock (NASDAQ:CHRN) rose 6.6% on Wednesday . The stock traded as high as $18.87 and last traded at $18.83. 39,104 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 243,492 shares. The stock had previously closed at $17.66.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $6.00.

ChronoScale Corporation Common Stock Stock Up 5.6%

The stock has a market cap of $2.92 billion, a P/E ratio of -3.73 and a beta of 0.98. The firm has a 50 day simple moving average of $21.49 and a 200-day simple moving average of $16.45. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.06.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its earnings results on Wednesday, August 19th. The company reported ($0.12) EPS for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The business had revenue of $18.40 million for the quarter. On average, equities research analysts forecast that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Citadel Advisors LLC acquired a new stake in ChronoScale Corporation Common Stock during the 3rd quarter worth approximately $198,000. Shay Capital LLC acquired a new position in ChronoScale Corporation Common Stock in the 3rd quarter valued at $67,000. Virtu Financial LLC bought a new position in ChronoScale Corporation Common Stock during the 3rd quarter worth $57,000. Geode Capital Management LLC increased its position in ChronoScale Corporation Common Stock by 68.9% during the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after buying an additional 10,281 shares during the period. Finally, Roble Belko & Company Inc lifted its holdings in shares of ChronoScale Corporation Common Stock by 104.5% during the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after buying an additional 1,195 shares in the last quarter. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.